Indaptus Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-237.7K | $1.6M |
| FY2021 | — | $35.9M | $39.1M |
| FY2022 | — | $24.6M | $9.6M |
| FY2023 | — | $12.1M | $13.4M |
| FY2024 | — | $3.9M | $5.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-237.7K | $1.6M |
| FY2021 | — | $35.9M | $39.1M |
| FY2022 | — | $24.6M | $9.6M |
| FY2023 | — | $12.1M | $13.4M |
| FY2024 | — | $3.9M | $5.8M |